Late-stage drug development program for Obstructive Sleep Apnea. (For Wholesale Investors Only)
Objective
Growth
Asset Class
Alternative Investment
Min. Investment
$10,000
Liquidity
Illiquid
Industry
Biotechnology, Healthcare & Medical
Availability
Open for investment
Funding Stage
series A, B, C
Structure
Company